Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002408611 | SCV002716584 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-11-12 | criteria provided, single submitter | clinical testing | The p.K585N variant (also known as c.1755G>T), located in coding exon 9 of the BRCA2 gene, results from a G to T substitution at nucleotide position 1755. The lysine at codon 585 is replaced by asparagine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of p.K585N remains unclear. |
University of Washington Department of Laboratory Medicine, |
RCV002408611 | SCV003851613 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |
Sharing Clinical Reports Project |
RCV000082890 | SCV000114964 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2010-02-24 | no assertion criteria provided | clinical testing |